Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation

Blood. 2003 May 1;101(9):3730-40. doi: 10.1182/blood-2002-08-2568. Epub 2003 Jan 2.

Abstract

Interactions between killer immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) class I ligands influence development of natural killer (NK) cell repertoire and response to infection, cancer, and allogeneic tissue. As KIRs and HLA class I molecules are highly polymorphic, clinical allogeneic hematopoietic cell transplantation is predicted to frequently involve KIR mismatch, and thus to provide a unique system for study of human NK cell receptor repertoire development. Eighteen leukemia patients undergoing HLA-matched transplantation and their donors were analyzed for KIR genotype. Ten of 13 HLA-identical donor-patient pairs were KIR mismatched and 3 were matched; all HLA-matched unrelated pairs were KIR mismatched. Reconstitution of recipient NK cell repertoire following transplantation was examined using flow cytometry and monoclonal antibodies specific for KIR and CD94:NKG2A. These data form 3 groups. Six to 9 months after transplantation, 8 patients (group 1) reconstituted an NK cell repertoire resembling that of their donor, and for KIR-mismatched transplants, distinct from the recipient before transplantation. In the first year after transplantation, 5 patients (group 2) exhibited a generally depressed frequency of KIR-expressing NK cells and concomitant high frequency of CD94:NKG2A expression. By 3 years after transplantation, the frequency of KIR-expressing NK cells had increased to donor values, in the 3 patients from group 2 analyzed for this period. The remaining 5 patients experienced severe clinical complications following transplantation and displayed unique features in their NK cell receptor reconstitution. These results demonstrate that a majority of HLA-matched hematopoietic cell transplantations involve KIR mismatch and reveal differences in NK cell repertoire having potential impact for immune responsiveness and transplantation outcome.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Antigens, CD / genetics*
  • Antigens, CD / immunology
  • Cell Lineage
  • Cytotoxicity, Immunologic
  • Female
  • Follow-Up Studies
  • Genotype
  • Graft Survival
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / immunology
  • HLA Antigens / genetics
  • Histocompatibility
  • Humans
  • Killer Cells, Natural / cytology*
  • Killer Cells, Natural / immunology
  • Lectins, C-Type / genetics*
  • Lectins, C-Type / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Leukemia, Myeloid / therapy
  • Male
  • Middle Aged
  • NK Cell Lectin-Like Receptor Subfamily C
  • NK Cell Lectin-Like Receptor Subfamily D
  • Peripheral Blood Stem Cell Transplantation* / adverse effects
  • Receptors, Immunologic / genetics*
  • Receptors, Immunologic / immunology
  • Receptors, KIR
  • Receptors, Natural Killer Cell
  • Remission Induction
  • Transplantation Chimera
  • Transplantation, Homologous / adverse effects
  • Transplantation, Homologous / immunology
  • Treatment Outcome

Substances

  • Antigens, CD
  • HLA Antigens
  • KLRC1 protein, human
  • KLRD1 protein, human
  • Lectins, C-Type
  • NK Cell Lectin-Like Receptor Subfamily C
  • NK Cell Lectin-Like Receptor Subfamily D
  • Receptors, Immunologic
  • Receptors, KIR
  • Receptors, Natural Killer Cell